الفهرس 
Nanocomposite materials
MaterialsOnly 14 pages are availabe for public view
 |  | from | 257 |  |  |
| | | from | 257 | | |
Abstract
Recently, drug targeting has been getting much attention by the researchers for treating cancer. Nanoparticles (NPs) as a key tool in targeted cancer treatment have been widely investigated, and they have shown promising potential. A critical advantage in treating cancer with NPs, as NPs featured a smaller particle size and a high surface area, they could enter the blood circulation via the capillaries and pass through the endothelial cell gap and migrate to the tumor site, thus achieving a drug-targeted distribution and enhancing the bioavailability of the drug. Moreover, NPs could control the
release of the drug through the degradation of biomaterial in a long and smooth pattern, ultimately prolonging the eliminating half-life, improving the effective blood concentration, and reducing the dosing frequency.